APP下载

临床药师参与胃癌术后十二指肠残端瘘合并吸入性肺炎病例的药学实践

2021-06-20闫成苏彦雷刘婷婷薛倩刘倩

上海医药 2021年9期

闫成 苏彦雷 刘婷婷 薛倩 刘倩

摘 要 临床药师在1例胃癌术后十二指肠残端瘘合并吸入性肺炎患者的治疗过程中,积极参与抗感染方案的制定与调整,密切监测患者临床症状、炎性指标的变化,对患者的发热原因进行分析,指导患者正确使用雾化吸入装置并积极促进会厌功能恢复,最终患者的病情得到了控制,治疗效果较好,体现了临床药师的服务价值。

关键词 十二指肠残端瘘 吸入性肺炎 包裹性积液 临床药师

中图分类号:R735.2; R563.1 文献标志码:C 文章编号:1006-1533(2021)09-0052-04

*基金项目:河北省卫生健康委科研基金项目(20191055)

Clinical pharmacists participate in the pharmaceutical practice of the treatment of a patient with duodenal stump fistula complicated with aspiration pneumonia after gastric cancer surgery*

YAN Cheng1**, SU Yanlei1, LIU Tingting1, XUE Qian1, LIU Qian2

(1. Department of Pharmacy, Bethune International Peace Hospital; 2. Department of Geriatrics, Hebei Youfu Hospital, Shijiazhuang 050082, China)

ABSTRACT During the treatment of a patient with duodenal stump fistula complicated with aspiration pneumonia after gastric cancer surgery, clinical pharmacists actively participated in the formulation and adjustment of anti-infection scheme, closely monitored the changes of clinical symptoms and inflammatory indexes, analyzed the causes of fever, guided the patients to correctly use the atomization inhalation device and actively promote the recovery of epiglottis function. The treatment effect was good and the patients condition was controlled and she finally was discharged, which reflects the service value of clinical pharmacists.

KEy WORDS duodenal stump fistula; aspiration pneumonia; encapsulated effusion; clinical pharmacist

胃癌是全球发病第6位的常见恶性肿瘤,我国发病例数约占全球的50%,严重威胁人民的生命健康[1-2]。全胃根治性切除术是治疗胃癌的一个重要手段,十二指肠残端瘘是胃切除术后早期严重的并发症,发生率为1%~4%,可导致胆汁等消化液大量流失、严重腹腔感染,甚至危及生命[3-5]。本研究就1例胃癌术后十二指肠残端瘘合并吸入性肺炎病例的诊治过程,探讨临床药师在实际工作中,如何根据疾病特点及患者状况有针对性地提供药学服务,促进患者康复。

1 病史资料

一例女性患者,61岁,体重53 kg,因“上腹部不适3月余”于2020年5月11日入院。患者于2020年2月无明显诱因间断出现上腹部隐痛,当地就诊,查胃镜示“贲门胃底癌”,病理诊断:黏膜腺体重度异增癌变,为行手术治疗入我院。患者自发病以来精神可,食欲差,二便正常,体重无明显增减。患者2017年因胆囊炎行胆囊切除术,术后恢复良好。……

登录APP查看全文